Guillermo Romero-Farina

Dr. Guillermo Romero-Farina

orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 September 2019 in European Heart Journal - Cardiovascular Imaging
Verified
Journal Article
Closed access
ARAlbert Roque
Albert Roque
MPMaría Nazarena Pizzi
María Nazarena Pizzi
NFNúria Fernández-Hidalgo
Núria Fernández-Hidalgo
EPEduard Permanyer
Eduard Permanyer
HCHug Cuellar-Calabria
Hug Cuellar-Calabria
SASantiago Aguadé-Bruix
Santiago Aguadé-Bruix
Aims: To define characteristic PET/CTA patterns of FDG uptake and anatomic changes following prosthetic heart valves (PVs) implantation over time, to help not to misdiagnose post-operative inflammation and avoid false-positive cases.Methods and results: Prospective evaluation of 37 post-operative patients without suspected infection that underwent serial cardiac PET/CTA examinations at 1, 6, and 12 months after surgery, in which metabolic features (FDG uptake distribution pattern and intensity) and anatomic changes were evaluated. Standardized uptake values (SUVs) were obtained and a new measure, the valve uptake index (VUI), (SUVmax–SUVmean)/SUVmax, was tested to homogenize SUV results.In total, 111 PET/CTA scans were performed in 37 patients (19 aortic and 18 mitral valves). FDG uptake was visually detectable in 79.3% of patients and showed a diffuse, homogeneous distribution pattern in 93%. Quantitative analysis yielded a mean maximum standardized uptake value (SUVmax) of 4.46 ± 1.50 and VUI of 0.35 ± 0.10. There were no significant differences in FDG distribution or uptake values between 1, 6, or 12 months. No abnormal anatomic changes or endocarditis lesions were detected in any patient during follow-up.Conclusions: FDG uptake, often seen in recently implanted PVs, shows a characteristic pattern of post-operative inflammation and, in the absence of associated anatomic lesions, could be considered a normal finding. These features remain stable for at least 1 year after surgery, so questioning the recommended 3-month safety period. A new measure, the VUI, can be useful for evaluating the FDG distribution pattern.

1 February 2015 in Journal of Nuclear Cardiology
Verified
Journal Article
Closed access
PDF file
GRGuillermo Romero-Farina
Guillermo Romero-Farina
JCJaume Candell-Riera
Jaume Candell-Riera
SASantiago Aguadé-Bruix
Santiago Aguadé-Bruix
IFIgnacio Ferreira-González
Ignacio Ferreira-González
GCGemma Cuberas-Borrós
Gemma Cuberas-Borrós
DGDavid García-Dorado
David García-Dorado

1 June 2005 in Stroke
Verified
Journal Article
Closed access
PDF file
JAJuan F. Arenillas
Juan F. Arenillas
JCJaume Candell-Riera
Jaume Candell-Riera
GRGuillermo Romero-Farina
Guillermo Romero-Farina
CMCarlos A. Molina
Carlos A. Molina
PCPilar Chacón
Pilar Chacón
JSJosé Alvarez Sabín
José Alvarez Sabín
Background and Purpose— Optimization of coronary risk evaluation in stroke patients has been encouraged. The relationship between symptomatic intracranial atherosclerosis and occult coronary artery disease (CAD) has not been evaluated sufficiently. We aimed to investigate the prevalence of silent myocardial ischemia in patients with symptomatic intracranial atherosclerosis and to identify factors associated with its presence. Methods— From 186 first-ever transient ischemic attack or ischemic stroke patients with intracranial stenoses, 65 fulfilled selection criteria, including angiographic confirmation of a symptomatic atherosclerotic stenosis and absence of known CAD. All patients underwent a maximal-stress myocardial perfusion single-photon emission computed tomography (SPECT). Lipoprotein(a) [Lp(a)], C-reactive protein, and homocysteine (Hcy) levels were determined before SPECT. Results— Stress-rest SPECT detected reversible myocardial perfusion defects in 34 (52%) patients. Vascular risk factors associated with a pathologic SPECT were hypercholesterolemia ( P =0.045), presence of >2 risk factors ( P =0.004) and high Lp(a) ( P =0.023) and Hcy levels ( P =0.018). Ninety percent of patients with high Lp(a) and Hcy levels had a positive SPECT. Existence of a stenosed intracranial internal carotid artery (ICA; odds ratio [OR], 7.22, 2.07 to 25.23; P =0.002) and location of the symptomatic stenosis in vertebrobasilar arteries (OR, 4.89, 1.19 to 20.12; P =0.027) were independently associated with silent myocardial ischemia after adjustment by age, sex, and risk factors. Conclusions— More than 50% of the patients with symptomatic intracranial atherosclerosis and not overt CAD show myocardial perfusion defects on stress-rest SPECT. Stenosed intracranial ICA, symptomatic vertebrobasilar stenosis and presence of high Lp(a) and Hcy levels may characterize the patients at a higher risk for occult CAD.

1 December 2015 in Journal of Nuclear Cardiology
Verified
Journal Article
Closed access
PDF file
GRGuillermo Romero-Farina
Guillermo Romero-Farina
SASantiago Aguadé-Bruix
Santiago Aguadé-Bruix
JCJaume Candell-Riera
Jaume Candell-Riera
MPMaría Nazarena Pizzi
María Nazarena Pizzi
DGDavid García-Dorado
David García-Dorado

1 July 2013 in Circulation: Cardiovascular Imaging
Verified
Journal Article
Open access
PDF file
JCJaume Candell-Riera
Jaume Candell-Riera
IFIgnacio Ferreira-González
Ignacio Ferreira-González
JMJosep Ramon Marsal Mora
Josep Ramon Marsal Mora
SASantiago Aguadé-Bruix
Santiago Aguadé-Bruix
GCGemma Cuberas-Borrós
Gemma Cuberas-Borrós
DGDavid García-Dorado
David García-Dorado
Background—: The incremental prognostic value of myocardial perfusion–gated single photon emission computed tomography (MPGS) compared with exercise test has not yet been properly evaluated. Methods and Results—: Five thousand six hundred seventy-two consecutive patients with known or suspected coronary disease undergoing exercise MPGS between 1997 and 2007 were included. Three-year predictive models for total death and death from cardiovascular causes or acute myocardial infarction (ie, major cardiovascular events [MCE]) were built using Cox-regression modeling, including only the clinical information. Then the exercise and MPGS information was sequentially added. The added discriminative ability of exercise test information and MPGS was assessed by net reclassification improvement and integrated discrimination improvement. The increase in predictive ability of exercise information for death and MCE was high as assessed by net reclassification improvement (0.199 and 0.263) and integrated discrimination improvement (0.042 and 0.021). The only variable of MPGS associated with total death was ejection fraction (hazard ratio, 0.84; 95% confidence interval, 0.79–0.89; P <0.001). Global stress ischemic score emerged as an additional variable associated with MCE (hazard ratio, 1.07; 95% confidence interval, 1.02–1.12; P =0.007). Adding MPGS information barely improved the prognostic value for total death (net reclassification improvement, 0.017; integrated discrimination improvement, 0.013), but it increased for MCE (net reclassification improvement, 0.122; integrated discrimination improvement, 0.033). Conclusions—: Adding MPGS information to exercise information does not improve prediction of total death, although it allows a more accurate prediction of MCE.

6 January 2022 in European Heart Journal - Cardiovascular Imaging
Verified
Journal Article
Open access
PDF file
ARAlbert Roque
Albert Roque
MPMaría Nazarena Pizzi
María Nazarena Pizzi
NFNúria Fernández-Hidalgo
Núria Fernández-Hidalgo
GRGuillermo Romero-Farina
Guillermo Romero-Farina
GBGemma Burcet
Gemma Burcet
HCHug Cuellar-Calabria
Hug Cuellar-Calabria
Diagnosis of prosthetic valve endocarditis (PVE) by positron emission computed tomography angiography (PET/CTA) is based on visual and quantitative morpho-metabolic features. However, the fluorodeoxyglucose (FDG) uptake pattern can be sometimes visually unclear and susceptible to subjectivity. This study aimed to validate a new parameter, the valve uptake index [VUI, maximum standardized uptake value (SUVmax)−mean standardized uptake value (SUVmean)/SUVmax], designed to provide a more objective indication of the distribution of metabolic activity. Secondly, to re-evaluate the utility of traditionally used PVE imaging criteria and determine the potential value of adding the VUI in the diagnostic algorithm of PVE. Retrospective analysis of 122 patients (135 prosthetic valves) admitted for suspicion of endocarditis, with a conclusive diagnosis of definite (N = 57) or rejected (N = 65) PVE, and who had undergone a cardiac PET/CTA scan as part of the diagnostic evaluation. We measured the VUI and recorded the SUVmax, SUVratio, uptake pattern, and the presence of endocarditis-related anatomic lesions. The VUI, SUVmax, and SUVratio values were 0.54 ± 0.1 vs. 0.36 ± 0.08, 7.68 ± 3.07 vs. 3.72 ± 1.11, and 4.28 ± 1.93 vs. 2.16 ± 0.95 in the ‘definite’ PVE group vs. the ‘rejected’ group, respectively (mean ± SD; P < 0.001). A cut-off value of VUI > 0.45 showed a sensitivity, specificity, and diagnostic accuracy for PVE of 85%, 88%, and 86.7% and increased diagnostic ability for confirming endocarditis when combined with the standard diagnostic criteria. The VUI demonstrated good diagnostic accuracy for PVE, even increasing the diagnostic power of the traditionally used morphometabolic parameters, which also confirmed their own diagnostic performance. More research is needed to assess whether the integration of the VUI into the PVE diagnostic algorithm may clarify doubtful cases and thus improve the diagnostic yield of PET/CTA.